| 10:00-11:00 |
Á¦111Â÷ Çмú´ëȸ °³È¸½Ä
¸¶Á¦½ºÆ½ º¼·ë (2F)
|
|---|
| Chair(s) |
±è¿µÇÑ ( ´ëÇÑ»êºÎÀΰúÇÐȸ »ç¹«ÃÑÀå , KOREA ) |
|---|
| 10:00-10:05 |
Opening Remarks
Ahm Kim ( President of KSOG , Korea ) |
|---|
| 10:05-10:10 |
Opening Remarks
Young Tae Kim ( Chairman of KSOG , Korea ) |
|---|
| 10:10-10:20 |
Certificate of Appreciation Award Ceremony
Ahm Kim ( President of KSOG , Korea ) , Young Tae Kim ( Chairman of KSOG , Korea ) |
|---|
| 10:20-10:30 |
Honorary Member Appointment Ceremony
Young Tae Kim ( Chairman of KSOG , Korea ) |
|---|
| 10:30-10:35 |
Presentation of Plaque of Appreciation
Young Tae Kim ( Chairman of KSOG , Korea ) |
|---|
| 10:35-10:45 |
Obstetrics & Gynecology Science Medical Award
|
|---|
| 10:45-10:50 |
KSOG Medical Award [ÀÎ¼Û¼Û¸íµµÀÇÇлó]
|
|---|
| 10:50-11:00 |
Looking back on the past 2 years..
Young Tae Kim ( Chairman of KSOG , Korea ) |
|---|
| 11:00-12:30 |
Plenary Session
¸¶Á¦½ºÆ½ º¼·ë (2F)
|
|---|
| Chair(s) |
Hye Sung Won ( Univ. of Ulsan , KOREA ) Jung-Ho Shin ( Korea Univ. , Korea ) |
|---|
| 11:00-11:20 |
Inflammation and embryo implantation, the role of dendritic cells
Gil Mor ( Wayne State University , USA ) |
|---|
| 11:20-11:40 |
A novel approach in medical management of dysmenorrhea
Yutaka Osuga ( Teikyo University , Japan ) |
|---|
| 11:40-12:00 |
The use of uterine manipulator in endometrial cancer surgery: available evidence and future perspectives.
Stefano Uccella ( University of Verona , Italy ) |
|---|
| 12:00-12:20 |
Maternal mortality in Taiwan
Ming-Chao Huang ( Mackay Memorial Hospital , TAIWAN ) |
|---|
| 12:20-12:30 |
Discussion
|
|---|
| 12:30-13:30 |
Luncheon Symposium
¸¶Á¦½ºÆ½ º¼·ë (2F)
|
|---|
| Chair(s) |
ÀÌÀç°ü ( °í·ÁÀÇ´ë , KOREA ) |
|---|
| 12:30-12:50 |
HPV¹é½Å,Á߳⿩¼º°ú ³²¿© ¿¹¹æÀÇ Á߿伺 ¹× ±¹³»¿Ü ÃÖ½ÅÁö°ß
¹Î°æÁø ( °í·ÁÀÇ´ë , KOREA ) |
|---|
| 13:30-14:50 |
Sponsor Symposium
¸¶Á¦½ºÆ½ º¼·ë (2F)
|
|---|
| Chair(s) |
ÀÌÅÂÈ ( °í½ÅÀÇ´ë , KOREA ) |
|---|
| 13:30-13:50 |
Development of fetal cardiac biometry using automated system in Korean population
À̹̿µ ( ¿ï»êÀÇ´ë , KOREA ) |
|---|
| 13:50-14:10 |
New updates on the Management of Preterm Labor
±èÈñ¼± ( ±¹¹Î°Ç°º¸Çè°ø´Ü , KOREA ) |
|---|
| 14:10-14:30 |
»êºÎÀΰú ¼ö¼ú¿¡¼ÀÇ °¡µñ½º È¿°ú
±è»óÀÏ ( °¡Å縯ÀÇ´ë , KOREA ) |
|---|
| 14:30-14:50 |
Clinical Update on Micronized Vaginal Progesterone for Miscarriage Prevention
¼³ÇöÁÖ ( °í·ÁÀÇ´ë , KOREA ) |
|---|
| 14:50-16:30 |
Featured Oral Presentation [OB/GO]
¸¶Á¦½ºÆ½ º¼·ë (2F)
|
|---|
| Chair(s) |
ÃÖ¼®ÁÖ ( ¼º±Õ°üÀÇ´ë , KOREA ) ¼º¼®ÁÖ ( Â÷ÀǰúÇдë , KOREA ) |
|---|
| 14:50-15:00OB10 |
A study on the association between PM2.5 exposure and urinary lipidomic metabolite changes during pregnancy
¹Ú¼±È ( ÀÌÈÀÇ´ë , KOREA ) |
|---|
| 15:00-15:10OB11 |
Distinct Vaginal Microbiome in Term and Preterm Deliveries
±è¼öÁ¤ ( ÀÌÈÀÇ´ë , KOREA ) |
|---|
| 15:10-15:20OB12 |
Clinical Impact of a Digital Health Strategy in Pregnancies Complicated by Gestational Diabetes
À̼±ÀÇ ( °¡Å縯ÀÇ´ë , KOREA ) |
|---|
| 15:20-15:30OB13 |
Comparison of cumulative population doubling level of Wharton¡¯s jelly-derived mesenchymal stem cells from Pre-eclamptic and Normal Pregnancies
¾È¼±¾Æ ( °¡ÃµÀÇ´ë , KOREA ) |
|---|
| 15:30-15:40OB14 |
Pre-pregnancy steatotic liver disease and risk of gestational diabetes mellitus: a nationwide population-based cohort study
±è¿ìÁ¤ ( °¡Å縯ÀÇ´ë , KOREA ) |
|---|
| 15:40-15:50GO11 |
Significance of Zonula occludens-1 (ZO-1) tight junction protein in tumorigenesis and cancer progression in human ovarian cancer cells
À±ÇüÁØ ( ºÎ»êÀÇ´ë , KOREA ) |
|---|
| 15:50-16:00GO12 |
Intrauterine Bio-Plasma Device as a Novel Non-Surgical Therapy for Endometrial Cancer
±è¼Ò¿µ ( °æÈñÀÇ´ë , KOREA ) |
|---|
| 16:00-16:10GO13 |
Gynecologic Cancer Disparities in Women With Intellectual and Developmental Disabilities: A Higher Risk of Uterine Cancer
¼ÛÈñ°æ ( °¡Å縯ÀÇ´ë , KOREA ) |
|---|
| 16:10-16:20GO14 |
Healthcare Utilization of Transman Cohort in South Korea: Cervical Cancer Screening and Human Papillomavirus Vaccination
±è°¡Àº ( ±¹¸³Áß¾ÓÀÇ·á¿ø , KOREA ) |
|---|
| 16:20-16:30GO15 |
Cervical Cancer Diagnosed in Pregnancy: Outcomes of Neoadjuvant Chemotherapy Followed by Cesarean Radical Hysterectomy
°¿ÁÁÖ ( ¿ï»êÀÇ´ë , KOREA ) |
|---|